Companies & Industry »Quarterly P & L
Surya Pharmaceutical Ltd - Quarterly P & L

BSE   25 May 12 | 12:00 AM

3.47 -0.16 (-4.41%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532516
Face Value: 1

NSE   25 May 12 | 12:00 AM

3.50 -0.15 (-4.11%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: SURYAPHARM
Performance
1 Week : Rs 4.10 (-15.37%)
1 Month : Rs 6.59 (-47.34%)
1 Year : Rs 20.00 (-82.65%)
change companytradenow

Quarterly P&L Profit & Loss Balance Sheet Cash Flow Ratios Shareholding Pattern  
Note: 1 crore = 10 millionRs cr
No Consolidated Avaliable
Mar 2012Mar 2011YOYDec 2011QOQ
Operating Income216.78450.27-51.86551.06-60.66
Material Consumed295.40396.20-25.44413.55-28.57
Manufacturing Expenses-65.11-48.62N.A.21.34-405.11
Personnel Expenses7.9712.93-38.3613.81-42.29
Cost Of Sales238.26360.51-33.91448.70-46.90
Selling & Adminstrative Expenses0.000.00N.A.0.00N.A.
Other Expenses27.4618.5248.2726.722.77
Expenses265.72379.03-29.89475.42-44.11
Operating Profit-48.9471.24-168.7075.64-164.70
Other Income0.000.00N.A.0.00N.A.
PBDIT-48.9471.24-168.7075.64-164.70
Financial Expenses52.7732.8260.7944.9917.29
Depreciation9.043.71143.678.951.01
Provisions & Write offs0.000.00N.A.0.00N.A.
PBT-110.7534.71-419.0721.70-610.37
Tax Charges0.006.92-100.000.00N.A.
Reported Net Profit-110.7527.79-498.5221.70-610.37
Total Non Recurring Items0.000.00N.A.0.00N.A.
Adjusted Net Profit-110.7527.79-498.5221.70-610.37
Equity Dividend (%)0.000.00N.A.0.00N.A.
Reserves and Surplus0.000.00N.A.0.00N.A.

Sensex

Company Price Gain (%)
GAIL (India)336.303.37
Tata Steel408.252.43
DLF188.451.89
St Bk of India2,005.001.74
Larsen & Toubro1,186.401.54

Online Portfolio

You can create Online Portfolio here using the below button.